About heather

This author has not yet filled in any details.
So far heather has created 521 blog entries.

Ink World | Schreiner MediPharm, Applied DNA Sciences Offer Forensic Counterfeit-Proof Feature for Pharma Labels

August 16, 2019 Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions, now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and [...]

Ink World | Schreiner MediPharm, Applied DNA Sciences Offer Forensic Counterfeit-Proof Feature for Pharma Labels2019-08-16T12:24:39-04:00

Innovate LI | For Applied DNA, New Blood — And A Shot In The Arm

AUGUST 12, 2019 By GREGORY ZELLER // Just 11 months after spinning off from its parent company, a Stony Brook startup with expansion in its DNA has made its first corporate acquisition. LineaRX, a subsidiary of Applied DNA Sciences, has acquired the physical assets and intellectual property of Vitatex Inc., a private biotech [...]

Innovate LI | For Applied DNA, New Blood — And A Shot In The Arm2019-08-14T10:04:26-04:00

Applied DNA Reports Fiscal Third Quarter 2019 Financial Results

STONY BROOK, N.Y. – August 13, 2019 - Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the "Company"), announced consolidated financial results for the fiscal 2019 third quarter ended June 30, 2019. “Our fiscal third quarter performance reflects our continuing abilities to monetize our molecular taggant technology and our diagnostic and therapeutic platforms [...]

Applied DNA Reports Fiscal Third Quarter 2019 Financial Results2019-08-13T16:37:07-04:00

Pharmaceutical Daily News | Schreiner MediPharm and Applied DNA Sciences Offer Forensic Counterfeit-Proof Feature for Pharma Labels

August 13, 2019 A new forensic authentication feature for pharmaceutical labels is offered by Schreiner MediPharm in cooperation with Applied DNA Sciences: SigNature® DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect their products against counterfeiting and patients against potential health risks. DNA markers are deemed [...]

Pharmaceutical Daily News | Schreiner MediPharm and Applied DNA Sciences Offer Forensic Counterfeit-Proof Feature for Pharma Labels2019-08-13T15:31:23-04:00

Contract Pharma | Schreiner MediPharm, Applied DNA Offer Forensic Authentication Feature

August 13, 2019 Schreiner MediPharm now offers a new forensic authentication feature for pharmaceutical labels in cooperation with Applied DNA Sciences. SigNature DNA is a high-security feature based on DNA markers with which pharmaceutical manufacturers can protect products against counterfeiting, and patients against potential health risks. DNA markers are deemed to be [...]

Contract Pharma | Schreiner MediPharm, Applied DNA Offer Forensic Authentication Feature2019-08-13T15:13:54-04:00

Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET

STONY BROOK, N.Y., August 6, 2019 – Applied DNA Sciences, Inc. (NASDAQ: APDN), announced today it plans to release financial results for its fiscal 2019 third quarter ended June 30, 2019 after market close on Tuesday, August 13, 2019. In conjunction with the release, the Company has scheduled a conference call at 4:30 p.m. Eastern [...]

Applied DNA Schedules Fiscal 2019 Third Quarter Financial Results Conference Call for Tuesday, August 13, 2019 at 4:30 PM ET2019-08-13T16:43:06-04:00

Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx

STONY BROOK, NY. August 12, 2019 – LineaRx, Inc. (“LineaRx”), a majority-owned subsidiary of Applied DNA Sciences, Inc. (NASDAQ: APDN) (“Applied DNA” or the “Company”) announced that, in a decision rendered on August 7, 2019, the Centers for Medicare and Medicaid Services (CMS) approved chimeric antigen receptor (CAR) T-cell therapies that fit the CMS [...]

Medicare Coverage of CAR T-Cell Therapy Holds Positive Implications for LineaRx2019-08-12T09:11:54-04:00

360DX | LineaRx Acquires Cancer Cell Analysis Firm Vitatex

August 8, 2019 NEW YORK — LineaRx said today that it has acquired the assets and intellectual property of Vitatex, a developer of invasive circulating tumor cell (iCTC) analysis technologies. According to LineaRx — an Applied DNA Sciences subsidiary formed around technologies for DNA design, manufacture, and chemical modification by large scale PCR —  Vitatex's technologies [...]

360DX | LineaRx Acquires Cancer Cell Analysis Firm Vitatex2019-08-09T14:17:23-04:00

LineaRx Acquires Assets and Intellectual Property of Vitatex

STONY BROOK, NY. August 8, 2017 – LineaRx, Inc. (“LineaRx”), a wholly-owned subsidiary of Applied DNA Sciences, Inc. (“Applied DNA or the Company,” NASDAQ: APDN), announced today that it has acquired the physical assets and Intellectual Property (IP) of Vitatex Inc. (“Vitatex”), a private biotechnology company focused on advancing personalized medicine with [...]

LineaRx Acquires Assets and Intellectual Property of Vitatex2019-08-08T10:04:47-04:00

Applied DNA Signs Master Services Agreement with Schreiner Group to Deliver SigNature® DNA Labels to Protect Pharmaceutical Supply Chains

STONY BROOK, N.Y. August 7, 2019 – Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”, the “Company”), a leader in PCR-based DNA manufacturing for product authenticity and traceability solutions, announced today the signing of a Master Services Agreement with Germany-based Schreiner Group, an award-winning 68-year old company specializing in innovative, functional labels and [...]

Applied DNA Signs Master Services Agreement with Schreiner Group to Deliver SigNature® DNA Labels to Protect Pharmaceutical Supply Chains2019-08-06T15:10:41-04:00